Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating Envafolimab in combination with chemotherapy for metastatic or recurrent gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence [Phase 2]
Phase 2 clinical trial comparing postoperative immunotherapy to standard chemotherapy for high-risk gastric cancer after surgery.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating nivolumab in combination with chemotherapy for FGFR2-amplified metastatic gastric cancer with PD-L1 amplification a…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression [Phase 3]
Phase 3 trial investigating RC48-ADC in local advanced or metastatic gastric cancer with HER2 overexpression; status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy [Phase 2, Phase 3]
A trial update on KN026 in combination with chemotherapy for HER2-positive stomach (gastric) cancer patients after failure of first-line the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating traditional Chinese medicine treatment combined with adjuvant chemotherapy for gastric cancer stages IIIB and III…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]
Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal c…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]
Phase 1 trial evaluating safety and activity of 177Lu-3BP-227 in solid tumours expressing neurotensin receptor type 1; study terminated with…
-
FDA approval · 2023-12-11FDA Approved: OXALIPLATIN — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
The FDA approved a supplemental application for the generic oxaliplatin product submitted by Qilu Pharmaceutical Co., Ltd. under ANDA204368.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intraperitoneal paclitaxel with systemic mFOLFOX6 in gastric cancer with peritoneal carcinomatosis has c…
-
CLINICAL_TRIALS withdrawal · 2023-12-04Clinical Trial Update: Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections [Phase 3]
Phase 3 trial investigating viscosity of submucosal gel injections for endoscopic mucosal resection was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) [Phase 2]
Phase 2 study evaluating pembrolizumab in combination with TS-1 plus either cisplatin or oxaliplatin as first-line therapy for gastric cance…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating perioperative leucovorin, oxaliplatin, docetaxel and S-1 (LOTS) for locally advanced gastric or gastroesop…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation [Phase 2]
Phase II trial update for neoadjuvant laparoscopic HIPEC with chemoradiation in gastric/stomach cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients [Phase 1, Phase 2]
A two-part open-label Phase Ib/II study evaluated varlitinib in combination with weekly paclitaxel for EGFR/HER2 co-expressing advanced or m…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication [Phase 3]
Phase 3 clinical trial assessing eradication of Helicobacter pylori in family members to prevent gastric cancer; currently ACTIVE_NOT_RECRUI…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD [Phase 3]
A Phase 3 trial evaluating whether eradication of Helicobacter pylori affects gastric preneoplastic lesions and neoplasia after endoscopic s…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial investigating taurine combined with sintilimab and chemotherapy for advanced gastric cancer is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial [Phase 3]
Phase 3 clinical trial update for SARONG-II evaluating surveillance after resection of esophageal and gastric cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer [Phase 2]
Phase 2 clinical trial evaluating afatinib plus paclitaxel in advanced HER2-positive, trastuzumab-refractory esophagogastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy [Phase 2]
Phase 2 trial update comparing CNSI versus ICG for lymph node tracing during gastrectomy in gastric cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study [Phase 2]
Phase 2 neoadjuvant chemotherapy trial in advanced gastric cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A Phase I/II study evaluating atezolizumab in combination with olaparib in patients with advanced solid tumors, including ovarian, breast, s…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) [Phase 3]
Phase 3 trial MK-3475-859 (KEYNOTE-859) evaluating pembrolizumab plus chemotherapy versus placebo plus chemotherapy in gastric/GEJ adenocarc…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection [Phase 3]
Phase 3 randomized trial evaluating lymph node mapping with indocyanine green injected submucosally or subserosally in gastric cancer patien…